nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—kidney cancer	0.0973	1	CbGaD
Quetiapine—CYP3A7—Temsirolimus—kidney cancer	0.046	0.0844	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.046	0.0844	CbGbCtD
Quetiapine—CYP3A5—Temsirolimus—kidney cancer	0.0345	0.0633	CbGbCtD
Quetiapine—ABCB1—Temsirolimus—kidney cancer	0.0225	0.0412	CbGbCtD
Quetiapine—HTR2C—Sorafenib—kidney cancer	0.0215	0.0395	CbGbCtD
Quetiapine—CYP2D6—Temsirolimus—kidney cancer	0.0212	0.0388	CbGbCtD
Quetiapine—CYP3A4—Everolimus—kidney cancer	0.0199	0.0366	CbGbCtD
Quetiapine—CYP3A7—Paclitaxel—kidney cancer	0.0158	0.029	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0158	0.029	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.014	0.0257	CbGbCtD
Quetiapine—CYP3A7—Sorafenib—kidney cancer	0.014	0.0257	CbGbCtD
Quetiapine—CYP3A7—Vincristine—kidney cancer	0.0136	0.025	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0136	0.025	CbGbCtD
Quetiapine—CYP3A4—Temsirolimus—kidney cancer	0.0135	0.0247	CbGbCtD
Quetiapine—CYP3A5—Erlotinib—kidney cancer	0.0129	0.0237	CbGbCtD
Quetiapine—CYP3A5—Paclitaxel—kidney cancer	0.0118	0.0217	CbGbCtD
Quetiapine—ABCB1—Pazopanib—kidney cancer	0.0118	0.0217	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0114	0.0208	CbGbCtD
Quetiapine—CYP3A7—Sunitinib—kidney cancer	0.0114	0.0208	CbGbCtD
Quetiapine—CYP2D6—Pazopanib—kidney cancer	0.0111	0.0204	CbGbCtD
Quetiapine—ABCB1—Dactinomycin—kidney cancer	0.0108	0.0198	CbGbCtD
Quetiapine—CYP3A5—Sorafenib—kidney cancer	0.0105	0.0193	CbGbCtD
Quetiapine—CYP3A5—Vincristine—kidney cancer	0.0102	0.0187	CbGbCtD
Quetiapine—ABCB1—Gemcitabine—kidney cancer	0.00854	0.0157	CbGbCtD
Quetiapine—CYP3A5—Sunitinib—kidney cancer	0.00853	0.0156	CbGbCtD
Quetiapine—CYP2C19—Sorafenib—kidney cancer	0.00849	0.0156	CbGbCtD
Quetiapine—ABCB1—Erlotinib—kidney cancer	0.00842	0.0154	CbGbCtD
Quetiapine—CYP2D6—Erlotinib—kidney cancer	0.00794	0.0146	CbGbCtD
Quetiapine—ABCB1—Paclitaxel—kidney cancer	0.00771	0.0141	CbGbCtD
Quetiapine—CYP3A4—Pazopanib—kidney cancer	0.00707	0.013	CbGbCtD
Quetiapine—CHRM3—ureter—kidney cancer	0.00701	0.204	CbGeAlD
Quetiapine—ABCB1—Sorafenib—kidney cancer	0.00685	0.0126	CbGbCtD
Quetiapine—ABCB1—Vinblastine—kidney cancer	0.00676	0.0124	CbGbCtD
Quetiapine—ABCB1—Vincristine—kidney cancer	0.00665	0.0122	CbGbCtD
Quetiapine—CYP2D6—Sorafenib—kidney cancer	0.00645	0.0118	CbGbCtD
Quetiapine—CYP2D6—Vinblastine—kidney cancer	0.00637	0.0117	CbGbCtD
Quetiapine—ABCB1—Sunitinib—kidney cancer	0.00555	0.0102	CbGbCtD
Quetiapine—CYP3A4—Erlotinib—kidney cancer	0.00505	0.00926	CbGbCtD
Quetiapine—CYP3A4—Paclitaxel—kidney cancer	0.00462	0.00847	CbGbCtD
Quetiapine—ABCB1—Doxorubicin—kidney cancer	0.00416	0.00762	CbGbCtD
Quetiapine—CYP3A4—Sorafenib—kidney cancer	0.0041	0.00753	CbGbCtD
Quetiapine—CYP3A4—Vinblastine—kidney cancer	0.00405	0.00743	CbGbCtD
Quetiapine—CYP3A4—Vincristine—kidney cancer	0.00398	0.00731	CbGbCtD
Quetiapine—CYP2D6—Doxorubicin—kidney cancer	0.00392	0.00718	CbGbCtD
Quetiapine—CYP3A4—Sunitinib—kidney cancer	0.00333	0.0061	CbGbCtD
Quetiapine—CYP3A4—Doxorubicin—kidney cancer	0.00249	0.00457	CbGbCtD
Quetiapine—CYP2C19—urine—kidney cancer	0.00212	0.0616	CbGeAlD
Quetiapine—HTR2A—urine—kidney cancer	0.00135	0.0393	CbGeAlD
Quetiapine—CYP3A4—urine—kidney cancer	0.00125	0.0364	CbGeAlD
Quetiapine—CYP2D6—urine—kidney cancer	0.00123	0.0358	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00108	0.0316	CbGeAlD
Quetiapine—H1F0—nephron tubule—kidney cancer	0.000945	0.0275	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000928	0.027	CbGeAlD
Quetiapine—ADRA1B—renal system—kidney cancer	0.00091	0.0265	CbGeAlD
Quetiapine—ADRA1B—kidney—kidney cancer	0.00088	0.0256	CbGeAlD
Quetiapine—H1F0—renal system—kidney cancer	0.000859	0.025	CbGeAlD
Quetiapine—H1F0—kidney—kidney cancer	0.000831	0.0242	CbGeAlD
Quetiapine—H1F0—cortex of kidney—kidney cancer	0.000809	0.0236	CbGeAlD
Quetiapine—H1F0—gonad—kidney cancer	0.000771	0.0224	CbGeAlD
Quetiapine—H1F0—cardiac atrium—kidney cancer	0.00077	0.0224	CbGeAlD
Quetiapine—HTR1D—kidney—kidney cancer	0.000643	0.0187	CbGeAlD
Quetiapine—CHRM3—renal system—kidney cancer	0.000557	0.0162	CbGeAlD
Quetiapine—HTR1A—renal system—kidney cancer	0.000555	0.0162	CbGeAlD
Quetiapine—CHRM3—kidney—kidney cancer	0.000539	0.0157	CbGeAlD
Quetiapine—ADRA2C—nephron tubule—kidney cancer	0.000536	0.0156	CbGeAlD
Quetiapine—HTR7—renal system—kidney cancer	0.00053	0.0154	CbGeAlD
Quetiapine—HTR7—kidney—kidney cancer	0.000513	0.0149	CbGeAlD
Quetiapine—ADRA1A—renal system—kidney cancer	0.000511	0.0149	CbGeAlD
Quetiapine—ADRA2C—renal system—kidney cancer	0.000487	0.0142	CbGeAlD
Quetiapine—HTR7—gonad—kidney cancer	0.000475	0.0138	CbGeAlD
Quetiapine—ADRA2C—kidney—kidney cancer	0.000471	0.0137	CbGeAlD
Quetiapine—ADRA2C—cortex of kidney—kidney cancer	0.000459	0.0134	CbGeAlD
Quetiapine—CYP3A5—nephron tubule—kidney cancer	0.000449	0.0131	CbGeAlD
Quetiapine—ADRA2C—cardiac atrium—kidney cancer	0.000436	0.0127	CbGeAlD
Quetiapine—CYP3A5—renal system—kidney cancer	0.000408	0.0119	CbGeAlD
Quetiapine—CYP3A5—kidney—kidney cancer	0.000394	0.0115	CbGeAlD
Quetiapine—CYP3A5—cortex of kidney—kidney cancer	0.000384	0.0112	CbGeAlD
Quetiapine—ADRA2A—cortex of kidney—kidney cancer	0.000366	0.0107	CbGeAlD
Quetiapine—ADRA2A—gonad—kidney cancer	0.000349	0.0102	CbGeAlD
Quetiapine—ADRA2A—cardiac atrium—kidney cancer	0.000348	0.0101	CbGeAlD
Quetiapine—HTR2A—renal system—kidney cancer	0.000331	0.00962	CbGeAlD
Quetiapine—HTR2A—kidney—kidney cancer	0.00032	0.0093	CbGeAlD
Quetiapine—CYP3A4—renal system—kidney cancer	0.000306	0.00891	CbGeAlD
Quetiapine—CYP2D6—renal system—kidney cancer	0.000301	0.00877	CbGeAlD
Quetiapine—HTR2A—gonad—kidney cancer	0.000297	0.00863	CbGeAlD
Quetiapine—CYP3A4—kidney—kidney cancer	0.000296	0.00861	CbGeAlD
Quetiapine—CYP2D6—kidney—kidney cancer	0.000291	0.00848	CbGeAlD
Quetiapine—ABCB1—nephron tubule—kidney cancer	0.000238	0.00694	CbGeAlD
Quetiapine—ABCB1—renal system—kidney cancer	0.000217	0.00631	CbGeAlD
Quetiapine—ABCB1—kidney—kidney cancer	0.000209	0.0061	CbGeAlD
Quetiapine—ABCB1—cortex of kidney—kidney cancer	0.000204	0.00594	CbGeAlD
Quetiapine—ABCB1—gonad—kidney cancer	0.000194	0.00566	CbGeAlD
Quetiapine—Flupentixol—ABCB1—kidney cancer	9.08e-05	0.24	CrCbGaD
Quetiapine—Abdominal pain—Vincristine—kidney cancer	6.4e-05	0.000244	CcSEcCtD
Quetiapine—Infection—Paclitaxel—kidney cancer	6.39e-05	0.000244	CcSEcCtD
Quetiapine—Flatulence—Capecitabine—kidney cancer	6.37e-05	0.000243	CcSEcCtD
Quetiapine—Dry skin—Doxorubicin—kidney cancer	6.34e-05	0.000242	CcSEcCtD
Quetiapine—Dysgeusia—Capecitabine—kidney cancer	6.33e-05	0.000242	CcSEcCtD
Quetiapine—Dizziness—Sunitinib—kidney cancer	6.33e-05	0.000242	CcSEcCtD
Quetiapine—Feeling abnormal—Gemcitabine—kidney cancer	6.33e-05	0.000242	CcSEcCtD
Quetiapine—Shock—Paclitaxel—kidney cancer	6.32e-05	0.000242	CcSEcCtD
Quetiapine—Vomiting—Sorafenib—kidney cancer	6.32e-05	0.000242	CcSEcCtD
Quetiapine—Orthostatic hypotension—Doxorubicin—kidney cancer	6.32e-05	0.000241	CcSEcCtD
Quetiapine—Abdominal pain upper—Doxorubicin—kidney cancer	6.32e-05	0.000241	CcSEcCtD
Quetiapine—Nervous system disorder—Paclitaxel—kidney cancer	6.3e-05	0.000241	CcSEcCtD
Quetiapine—Hypokalaemia—Doxorubicin—kidney cancer	6.3e-05	0.000241	CcSEcCtD
Quetiapine—Thrombocytopenia—Paclitaxel—kidney cancer	6.29e-05	0.00024	CcSEcCtD
Quetiapine—Tachycardia—Paclitaxel—kidney cancer	6.27e-05	0.00024	CcSEcCtD
Quetiapine—Rash—Sorafenib—kidney cancer	6.27e-05	0.00024	CcSEcCtD
Quetiapine—Dermatitis—Sorafenib—kidney cancer	6.26e-05	0.000239	CcSEcCtD
Quetiapine—Back pain—Capecitabine—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Quetiapine—Breast disorder—Doxorubicin—kidney cancer	6.25e-05	0.000239	CcSEcCtD
Quetiapine—Skin disorder—Paclitaxel—kidney cancer	6.24e-05	0.000239	CcSEcCtD
Quetiapine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	6.23e-05	0.000238	CcSEcCtD
Quetiapine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.23e-05	0.000238	CcSEcCtD
Quetiapine—Headache—Sorafenib—kidney cancer	6.23e-05	0.000238	CcSEcCtD
Quetiapine—Muscle spasms—Capecitabine—kidney cancer	6.21e-05	0.000237	CcSEcCtD
Quetiapine—Hyperhidrosis—Paclitaxel—kidney cancer	6.21e-05	0.000237	CcSEcCtD
Quetiapine—Diarrhoea—Dactinomycin—kidney cancer	6.2e-05	0.000237	CcSEcCtD
Quetiapine—Nasopharyngitis—Doxorubicin—kidney cancer	6.19e-05	0.000236	CcSEcCtD
Quetiapine—Anorexia—Paclitaxel—kidney cancer	6.13e-05	0.000234	CcSEcCtD
Quetiapine—Gastritis—Doxorubicin—kidney cancer	6.12e-05	0.000234	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.1e-05	0.000233	CcSEcCtD
Quetiapine—Muscular weakness—Doxorubicin—kidney cancer	6.1e-05	0.000233	CcSEcCtD
Quetiapine—Vision blurred—Capecitabine—kidney cancer	6.09e-05	0.000233	CcSEcCtD
Quetiapine—Vomiting—Sunitinib—kidney cancer	6.08e-05	0.000232	CcSEcCtD
Quetiapine—Body temperature increased—Gemcitabine—kidney cancer	6.07e-05	0.000232	CcSEcCtD
Quetiapine—Tremor—Capecitabine—kidney cancer	6.06e-05	0.000231	CcSEcCtD
Quetiapine—Rash—Sunitinib—kidney cancer	6.03e-05	0.00023	CcSEcCtD
Quetiapine—Dermatitis—Sunitinib—kidney cancer	6.03e-05	0.00023	CcSEcCtD
Quetiapine—Abdominal distension—Doxorubicin—kidney cancer	6.02e-05	0.00023	CcSEcCtD
Quetiapine—Hypotension—Paclitaxel—kidney cancer	6.01e-05	0.000229	CcSEcCtD
Quetiapine—Ill-defined disorder—Capecitabine—kidney cancer	6e-05	0.000229	CcSEcCtD
Quetiapine—Headache—Sunitinib—kidney cancer	5.99e-05	0.000229	CcSEcCtD
Quetiapine—Influenza—Doxorubicin—kidney cancer	5.98e-05	0.000228	CcSEcCtD
Quetiapine—Dysphagia—Doxorubicin—kidney cancer	5.98e-05	0.000228	CcSEcCtD
Quetiapine—Asthma—Doxorubicin—kidney cancer	5.98e-05	0.000228	CcSEcCtD
Quetiapine—Anaemia—Capecitabine—kidney cancer	5.97e-05	0.000228	CcSEcCtD
Quetiapine—Hypersensitivity—Vincristine—kidney cancer	5.96e-05	0.000228	CcSEcCtD
Quetiapine—Eosinophilia—Doxorubicin—kidney cancer	5.92e-05	0.000226	CcSEcCtD
Quetiapine—Nausea—Sorafenib—kidney cancer	5.91e-05	0.000226	CcSEcCtD
Quetiapine—Pancreatitis—Doxorubicin—kidney cancer	5.86e-05	0.000224	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.86e-05	0.000224	CcSEcCtD
Quetiapine—Malaise—Capecitabine—kidney cancer	5.83e-05	0.000223	CcSEcCtD
Quetiapine—Angina pectoris—Doxorubicin—kidney cancer	5.82e-05	0.000223	CcSEcCtD
Quetiapine—Insomnia—Paclitaxel—kidney cancer	5.81e-05	0.000222	CcSEcCtD
Quetiapine—Vertigo—Capecitabine—kidney cancer	5.81e-05	0.000222	CcSEcCtD
Quetiapine—Asthenia—Vincristine—kidney cancer	5.81e-05	0.000222	CcSEcCtD
Quetiapine—Syncope—Capecitabine—kidney cancer	5.8e-05	0.000221	CcSEcCtD
Quetiapine—Leukopenia—Capecitabine—kidney cancer	5.79e-05	0.000221	CcSEcCtD
Quetiapine—Paraesthesia—Paclitaxel—kidney cancer	5.77e-05	0.000221	CcSEcCtD
Quetiapine—Vomiting—Dactinomycin—kidney cancer	5.76e-05	0.00022	CcSEcCtD
Quetiapine—Bronchitis—Doxorubicin—kidney cancer	5.75e-05	0.00022	CcSEcCtD
Quetiapine—Dyspnoea—Paclitaxel—kidney cancer	5.73e-05	0.000219	CcSEcCtD
Quetiapine—Somnolence—Paclitaxel—kidney cancer	5.71e-05	0.000218	CcSEcCtD
Quetiapine—Palpitations—Capecitabine—kidney cancer	5.71e-05	0.000218	CcSEcCtD
Quetiapine—Rash—Dactinomycin—kidney cancer	5.71e-05	0.000218	CcSEcCtD
Quetiapine—Nausea—Sunitinib—kidney cancer	5.68e-05	0.000217	CcSEcCtD
Quetiapine—Loss of consciousness—Capecitabine—kidney cancer	5.68e-05	0.000217	CcSEcCtD
Quetiapine—Dyspepsia—Paclitaxel—kidney cancer	5.66e-05	0.000216	CcSEcCtD
Quetiapine—Cough—Capecitabine—kidney cancer	5.64e-05	0.000215	CcSEcCtD
Quetiapine—Neutropenia—Doxorubicin—kidney cancer	5.59e-05	0.000214	CcSEcCtD
Quetiapine—Dysuria—Doxorubicin—kidney cancer	5.59e-05	0.000214	CcSEcCtD
Quetiapine—Decreased appetite—Paclitaxel—kidney cancer	5.59e-05	0.000213	CcSEcCtD
Quetiapine—Hypertension—Capecitabine—kidney cancer	5.58e-05	0.000213	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Doxorubicin—kidney cancer	5.56e-05	0.000212	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.55e-05	0.000212	CcSEcCtD
Quetiapine—Fatigue—Paclitaxel—kidney cancer	5.54e-05	0.000212	CcSEcCtD
Quetiapine—Diarrhoea—Vincristine—kidney cancer	5.54e-05	0.000212	CcSEcCtD
Quetiapine—Pollakiuria—Doxorubicin—kidney cancer	5.52e-05	0.000211	CcSEcCtD
Quetiapine—Asthenia—Gemcitabine—kidney cancer	5.51e-05	0.00021	CcSEcCtD
Quetiapine—Chest pain—Capecitabine—kidney cancer	5.5e-05	0.00021	CcSEcCtD
Quetiapine—Arthralgia—Capecitabine—kidney cancer	5.5e-05	0.00021	CcSEcCtD
Quetiapine—Myalgia—Capecitabine—kidney cancer	5.5e-05	0.00021	CcSEcCtD
Quetiapine—Pain—Paclitaxel—kidney cancer	5.5e-05	0.00021	CcSEcCtD
Quetiapine—Constipation—Paclitaxel—kidney cancer	5.5e-05	0.00021	CcSEcCtD
Quetiapine—Anxiety—Capecitabine—kidney cancer	5.48e-05	0.000209	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.46e-05	0.000209	CcSEcCtD
Quetiapine—Photosensitivity reaction—Doxorubicin—kidney cancer	5.46e-05	0.000209	CcSEcCtD
Quetiapine—Weight increased—Doxorubicin—kidney cancer	5.44e-05	0.000208	CcSEcCtD
Quetiapine—Discomfort—Capecitabine—kidney cancer	5.44e-05	0.000208	CcSEcCtD
Quetiapine—Pruritus—Gemcitabine—kidney cancer	5.43e-05	0.000208	CcSEcCtD
Quetiapine—Weight decreased—Doxorubicin—kidney cancer	5.41e-05	0.000207	CcSEcCtD
Quetiapine—Hyperglycaemia—Doxorubicin—kidney cancer	5.39e-05	0.000206	CcSEcCtD
Quetiapine—Dry mouth—Capecitabine—kidney cancer	5.38e-05	0.000206	CcSEcCtD
Quetiapine—Nausea—Dactinomycin—kidney cancer	5.38e-05	0.000206	CcSEcCtD
Quetiapine—Pneumonia—Doxorubicin—kidney cancer	5.36e-05	0.000205	CcSEcCtD
Quetiapine—Dizziness—Vincristine—kidney cancer	5.35e-05	0.000204	CcSEcCtD
Quetiapine—Infestation—Doxorubicin—kidney cancer	5.33e-05	0.000204	CcSEcCtD
Quetiapine—Infestation NOS—Doxorubicin—kidney cancer	5.33e-05	0.000204	CcSEcCtD
Quetiapine—Confusional state—Capecitabine—kidney cancer	5.32e-05	0.000203	CcSEcCtD
Quetiapine—Feeling abnormal—Paclitaxel—kidney cancer	5.3e-05	0.000202	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.29e-05	0.000202	CcSEcCtD
Quetiapine—Gastrointestinal pain—Paclitaxel—kidney cancer	5.26e-05	0.000201	CcSEcCtD
Quetiapine—Diarrhoea—Gemcitabine—kidney cancer	5.25e-05	0.000201	CcSEcCtD
Quetiapine—Infection—Capecitabine—kidney cancer	5.24e-05	0.0002	CcSEcCtD
Quetiapine—Stomatitis—Doxorubicin—kidney cancer	5.2e-05	0.000199	CcSEcCtD
Quetiapine—Jaundice—Doxorubicin—kidney cancer	5.2e-05	0.000199	CcSEcCtD
Quetiapine—Shock—Capecitabine—kidney cancer	5.19e-05	0.000198	CcSEcCtD
Quetiapine—Conjunctivitis—Doxorubicin—kidney cancer	5.18e-05	0.000198	CcSEcCtD
Quetiapine—Urinary tract infection—Doxorubicin—kidney cancer	5.18e-05	0.000198	CcSEcCtD
Quetiapine—Nervous system disorder—Capecitabine—kidney cancer	5.17e-05	0.000198	CcSEcCtD
Quetiapine—Thrombocytopenia—Capecitabine—kidney cancer	5.16e-05	0.000197	CcSEcCtD
Quetiapine—Tachycardia—Capecitabine—kidney cancer	5.15e-05	0.000197	CcSEcCtD
Quetiapine—Vomiting—Vincristine—kidney cancer	5.15e-05	0.000197	CcSEcCtD
Quetiapine—Skin disorder—Capecitabine—kidney cancer	5.12e-05	0.000196	CcSEcCtD
Quetiapine—Sweating—Doxorubicin—kidney cancer	5.11e-05	0.000195	CcSEcCtD
Quetiapine—Rash—Vincristine—kidney cancer	5.1e-05	0.000195	CcSEcCtD
Quetiapine—Hyperhidrosis—Capecitabine—kidney cancer	5.1e-05	0.000195	CcSEcCtD
Quetiapine—Dermatitis—Vincristine—kidney cancer	5.1e-05	0.000195	CcSEcCtD
Quetiapine—Body temperature increased—Paclitaxel—kidney cancer	5.08e-05	0.000194	CcSEcCtD
Quetiapine—Abdominal pain—Paclitaxel—kidney cancer	5.08e-05	0.000194	CcSEcCtD
Quetiapine—Nefazodone—ABCB1—kidney cancer	5.07e-05	0.134	CrCbGaD
Quetiapine—Headache—Vincristine—kidney cancer	5.07e-05	0.000194	CcSEcCtD
Quetiapine—Hepatobiliary disease—Doxorubicin—kidney cancer	5.04e-05	0.000193	CcSEcCtD
Quetiapine—Epistaxis—Doxorubicin—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Quetiapine—Anorexia—Capecitabine—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Quetiapine—Sinusitis—Doxorubicin—kidney cancer	5e-05	0.000191	CcSEcCtD
Quetiapine—Agranulocytosis—Doxorubicin—kidney cancer	4.98e-05	0.00019	CcSEcCtD
Quetiapine—Hypotension—Capecitabine—kidney cancer	4.93e-05	0.000188	CcSEcCtD
Quetiapine—Vomiting—Gemcitabine—kidney cancer	4.88e-05	0.000186	CcSEcCtD
Quetiapine—Bradycardia—Doxorubicin—kidney cancer	4.87e-05	0.000186	CcSEcCtD
Quetiapine—Olanzapine—ABCB1—kidney cancer	4.86e-05	0.128	CrCbGaD
Quetiapine—Rash—Gemcitabine—kidney cancer	4.84e-05	0.000185	CcSEcCtD
Quetiapine—Dermatitis—Gemcitabine—kidney cancer	4.84e-05	0.000185	CcSEcCtD
Quetiapine—Haemoglobin—Doxorubicin—kidney cancer	4.81e-05	0.000184	CcSEcCtD
Quetiapine—Headache—Gemcitabine—kidney cancer	4.81e-05	0.000184	CcSEcCtD
Quetiapine—Nausea—Vincristine—kidney cancer	4.81e-05	0.000184	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.81e-05	0.000184	CcSEcCtD
Quetiapine—Rhinitis—Doxorubicin—kidney cancer	4.8e-05	0.000183	CcSEcCtD
Quetiapine—Haemorrhage—Doxorubicin—kidney cancer	4.79e-05	0.000183	CcSEcCtD
Quetiapine—Hepatitis—Doxorubicin—kidney cancer	4.79e-05	0.000183	CcSEcCtD
Quetiapine—Clozapine—CYP1A1—kidney cancer	4.77e-05	0.126	CrCbGaD
Quetiapine—Insomnia—Capecitabine—kidney cancer	4.77e-05	0.000182	CcSEcCtD
Quetiapine—Hypoaesthesia—Doxorubicin—kidney cancer	4.76e-05	0.000182	CcSEcCtD
Quetiapine—Pharyngitis—Doxorubicin—kidney cancer	4.75e-05	0.000181	CcSEcCtD
Quetiapine—Paraesthesia—Capecitabine—kidney cancer	4.74e-05	0.000181	CcSEcCtD
Quetiapine—Hypersensitivity—Paclitaxel—kidney cancer	4.74e-05	0.000181	CcSEcCtD
Quetiapine—Urinary tract disorder—Doxorubicin—kidney cancer	4.73e-05	0.000181	CcSEcCtD
Quetiapine—Oedema peripheral—Doxorubicin—kidney cancer	4.71e-05	0.00018	CcSEcCtD
Quetiapine—Connective tissue disorder—Doxorubicin—kidney cancer	4.7e-05	0.00018	CcSEcCtD
Quetiapine—Dyspnoea—Capecitabine—kidney cancer	4.7e-05	0.00018	CcSEcCtD
Quetiapine—Trazodone—ABCB1—kidney cancer	4.69e-05	0.124	CrCbGaD
Quetiapine—Urethral disorder—Doxorubicin—kidney cancer	4.69e-05	0.000179	CcSEcCtD
Quetiapine—Dyspepsia—Capecitabine—kidney cancer	4.64e-05	0.000177	CcSEcCtD
Quetiapine—Visual impairment—Doxorubicin—kidney cancer	4.61e-05	0.000176	CcSEcCtD
Quetiapine—Asthenia—Paclitaxel—kidney cancer	4.61e-05	0.000176	CcSEcCtD
Quetiapine—Decreased appetite—Capecitabine—kidney cancer	4.59e-05	0.000175	CcSEcCtD
Quetiapine—Nausea—Gemcitabine—kidney cancer	4.56e-05	0.000174	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Capecitabine—kidney cancer	4.55e-05	0.000174	CcSEcCtD
Quetiapine—Fatigue—Capecitabine—kidney cancer	4.55e-05	0.000174	CcSEcCtD
Quetiapine—Pruritus—Paclitaxel—kidney cancer	4.55e-05	0.000174	CcSEcCtD
Quetiapine—Erythema multiforme—Doxorubicin—kidney cancer	4.53e-05	0.000173	CcSEcCtD
Quetiapine—Pain—Capecitabine—kidney cancer	4.51e-05	0.000172	CcSEcCtD
Quetiapine—Constipation—Capecitabine—kidney cancer	4.51e-05	0.000172	CcSEcCtD
Quetiapine—Eye disorder—Doxorubicin—kidney cancer	4.47e-05	0.000171	CcSEcCtD
Quetiapine—Tinnitus—Doxorubicin—kidney cancer	4.46e-05	0.00017	CcSEcCtD
Quetiapine—Cardiac disorder—Doxorubicin—kidney cancer	4.44e-05	0.00017	CcSEcCtD
Quetiapine—Diarrhoea—Paclitaxel—kidney cancer	4.4e-05	0.000168	CcSEcCtD
Quetiapine—Feeling abnormal—Capecitabine—kidney cancer	4.35e-05	0.000166	CcSEcCtD
Quetiapine—Angiopathy—Doxorubicin—kidney cancer	4.34e-05	0.000166	CcSEcCtD
Quetiapine—Immune system disorder—Doxorubicin—kidney cancer	4.32e-05	0.000165	CcSEcCtD
Quetiapine—Gastrointestinal pain—Capecitabine—kidney cancer	4.31e-05	0.000165	CcSEcCtD
Quetiapine—Mediastinal disorder—Doxorubicin—kidney cancer	4.31e-05	0.000165	CcSEcCtD
Quetiapine—Chills—Doxorubicin—kidney cancer	4.29e-05	0.000164	CcSEcCtD
Quetiapine—Dizziness—Paclitaxel—kidney cancer	4.25e-05	0.000162	CcSEcCtD
Quetiapine—Mental disorder—Doxorubicin—kidney cancer	4.19e-05	0.00016	CcSEcCtD
Quetiapine—Abdominal pain—Capecitabine—kidney cancer	4.17e-05	0.000159	CcSEcCtD
Quetiapine—Body temperature increased—Capecitabine—kidney cancer	4.17e-05	0.000159	CcSEcCtD
Quetiapine—Malnutrition—Doxorubicin—kidney cancer	4.17e-05	0.000159	CcSEcCtD
Quetiapine—Flatulence—Doxorubicin—kidney cancer	4.11e-05	0.000157	CcSEcCtD
Quetiapine—Tension—Doxorubicin—kidney cancer	4.09e-05	0.000156	CcSEcCtD
Quetiapine—Vomiting—Paclitaxel—kidney cancer	4.09e-05	0.000156	CcSEcCtD
Quetiapine—Dysgeusia—Doxorubicin—kidney cancer	4.08e-05	0.000156	CcSEcCtD
Quetiapine—Rash—Paclitaxel—kidney cancer	4.05e-05	0.000155	CcSEcCtD
Quetiapine—Dermatitis—Paclitaxel—kidney cancer	4.05e-05	0.000155	CcSEcCtD
Quetiapine—Nervousness—Doxorubicin—kidney cancer	4.05e-05	0.000155	CcSEcCtD
Quetiapine—Back pain—Doxorubicin—kidney cancer	4.03e-05	0.000154	CcSEcCtD
Quetiapine—Headache—Paclitaxel—kidney cancer	4.03e-05	0.000154	CcSEcCtD
Quetiapine—Muscle spasms—Doxorubicin—kidney cancer	4.01e-05	0.000153	CcSEcCtD
Quetiapine—Vision blurred—Doxorubicin—kidney cancer	3.93e-05	0.00015	CcSEcCtD
Quetiapine—Hypersensitivity—Capecitabine—kidney cancer	3.89e-05	0.000148	CcSEcCtD
Quetiapine—Ill-defined disorder—Doxorubicin—kidney cancer	3.87e-05	0.000148	CcSEcCtD
Quetiapine—Anaemia—Doxorubicin—kidney cancer	3.85e-05	0.000147	CcSEcCtD
Quetiapine—Agitation—Doxorubicin—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Quetiapine—Nausea—Paclitaxel—kidney cancer	3.82e-05	0.000146	CcSEcCtD
Quetiapine—Fluphenazine—ABCB1—kidney cancer	3.8e-05	0.1	CrCbGaD
Quetiapine—Asthenia—Capecitabine—kidney cancer	3.78e-05	0.000145	CcSEcCtD
Quetiapine—Malaise—Doxorubicin—kidney cancer	3.76e-05	0.000144	CcSEcCtD
Quetiapine—Vertigo—Doxorubicin—kidney cancer	3.74e-05	0.000143	CcSEcCtD
Quetiapine—Syncope—Doxorubicin—kidney cancer	3.74e-05	0.000143	CcSEcCtD
Quetiapine—Pruritus—Capecitabine—kidney cancer	3.73e-05	0.000143	CcSEcCtD
Quetiapine—Leukopenia—Doxorubicin—kidney cancer	3.73e-05	0.000142	CcSEcCtD
Quetiapine—Palpitations—Doxorubicin—kidney cancer	3.68e-05	0.000141	CcSEcCtD
Quetiapine—Loss of consciousness—Doxorubicin—kidney cancer	3.66e-05	0.00014	CcSEcCtD
Quetiapine—Cough—Doxorubicin—kidney cancer	3.64e-05	0.000139	CcSEcCtD
Quetiapine—Convulsion—Doxorubicin—kidney cancer	3.61e-05	0.000138	CcSEcCtD
Quetiapine—Diarrhoea—Capecitabine—kidney cancer	3.61e-05	0.000138	CcSEcCtD
Quetiapine—Hypertension—Doxorubicin—kidney cancer	3.6e-05	0.000137	CcSEcCtD
Quetiapine—Chest pain—Doxorubicin—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Quetiapine—Arthralgia—Doxorubicin—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Quetiapine—Myalgia—Doxorubicin—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Quetiapine—Anxiety—Doxorubicin—kidney cancer	3.53e-05	0.000135	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.52e-05	0.000135	CcSEcCtD
Quetiapine—Discomfort—Doxorubicin—kidney cancer	3.5e-05	0.000134	CcSEcCtD
Quetiapine—Dizziness—Capecitabine—kidney cancer	3.49e-05	0.000133	CcSEcCtD
Quetiapine—Dry mouth—Doxorubicin—kidney cancer	3.47e-05	0.000133	CcSEcCtD
Quetiapine—Confusional state—Doxorubicin—kidney cancer	3.43e-05	0.000131	CcSEcCtD
Quetiapine—Anaphylactic shock—Doxorubicin—kidney cancer	3.4e-05	0.00013	CcSEcCtD
Quetiapine—Infection—Doxorubicin—kidney cancer	3.38e-05	0.000129	CcSEcCtD
Quetiapine—Vomiting—Capecitabine—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Quetiapine—Shock—Doxorubicin—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Quetiapine—Nervous system disorder—Doxorubicin—kidney cancer	3.33e-05	0.000127	CcSEcCtD
Quetiapine—Thrombocytopenia—Doxorubicin—kidney cancer	3.33e-05	0.000127	CcSEcCtD
Quetiapine—Rash—Capecitabine—kidney cancer	3.33e-05	0.000127	CcSEcCtD
Quetiapine—Dermatitis—Capecitabine—kidney cancer	3.32e-05	0.000127	CcSEcCtD
Quetiapine—Tachycardia—Doxorubicin—kidney cancer	3.32e-05	0.000127	CcSEcCtD
Quetiapine—Headache—Capecitabine—kidney cancer	3.3e-05	0.000126	CcSEcCtD
Quetiapine—Skin disorder—Doxorubicin—kidney cancer	3.3e-05	0.000126	CcSEcCtD
Quetiapine—Hyperhidrosis—Doxorubicin—kidney cancer	3.29e-05	0.000126	CcSEcCtD
Quetiapine—Anorexia—Doxorubicin—kidney cancer	3.24e-05	0.000124	CcSEcCtD
Quetiapine—Hypotension—Doxorubicin—kidney cancer	3.18e-05	0.000121	CcSEcCtD
Quetiapine—Nausea—Capecitabine—kidney cancer	3.13e-05	0.00012	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.1e-05	0.000118	CcSEcCtD
Quetiapine—Insomnia—Doxorubicin—kidney cancer	3.08e-05	0.000117	CcSEcCtD
Quetiapine—Paraesthesia—Doxorubicin—kidney cancer	3.05e-05	0.000117	CcSEcCtD
Quetiapine—Trifluoperazine—ABCB1—kidney cancer	3.04e-05	0.0803	CrCbGaD
Quetiapine—Dyspnoea—Doxorubicin—kidney cancer	3.03e-05	0.000116	CcSEcCtD
Quetiapine—Somnolence—Doxorubicin—kidney cancer	3.02e-05	0.000115	CcSEcCtD
Quetiapine—Dyspepsia—Doxorubicin—kidney cancer	2.99e-05	0.000114	CcSEcCtD
Quetiapine—Decreased appetite—Doxorubicin—kidney cancer	2.96e-05	0.000113	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.94e-05	0.000112	CcSEcCtD
Quetiapine—Fatigue—Doxorubicin—kidney cancer	2.93e-05	0.000112	CcSEcCtD
Quetiapine—Pain—Doxorubicin—kidney cancer	2.91e-05	0.000111	CcSEcCtD
Quetiapine—Constipation—Doxorubicin—kidney cancer	2.91e-05	0.000111	CcSEcCtD
Quetiapine—Feeling abnormal—Doxorubicin—kidney cancer	2.8e-05	0.000107	CcSEcCtD
Quetiapine—Gastrointestinal pain—Doxorubicin—kidney cancer	2.78e-05	0.000106	CcSEcCtD
Quetiapine—Body temperature increased—Doxorubicin—kidney cancer	2.69e-05	0.000103	CcSEcCtD
Quetiapine—Abdominal pain—Doxorubicin—kidney cancer	2.69e-05	0.000103	CcSEcCtD
Quetiapine—Clozapine—ABCB1—kidney cancer	2.54e-05	0.067	CrCbGaD
Quetiapine—Hypersensitivity—Doxorubicin—kidney cancer	2.51e-05	9.57e-05	CcSEcCtD
Quetiapine—Asthenia—Doxorubicin—kidney cancer	2.44e-05	9.32e-05	CcSEcCtD
Quetiapine—Pruritus—Doxorubicin—kidney cancer	2.41e-05	9.19e-05	CcSEcCtD
Quetiapine—Diarrhoea—Doxorubicin—kidney cancer	2.33e-05	8.89e-05	CcSEcCtD
Quetiapine—Dizziness—Doxorubicin—kidney cancer	2.25e-05	8.59e-05	CcSEcCtD
Quetiapine—Vomiting—Doxorubicin—kidney cancer	2.16e-05	8.26e-05	CcSEcCtD
Quetiapine—Rash—Doxorubicin—kidney cancer	2.14e-05	8.19e-05	CcSEcCtD
Quetiapine—Dermatitis—Doxorubicin—kidney cancer	2.14e-05	8.18e-05	CcSEcCtD
Quetiapine—Headache—Doxorubicin—kidney cancer	2.13e-05	8.14e-05	CcSEcCtD
Quetiapine—Nausea—Doxorubicin—kidney cancer	2.02e-05	7.72e-05	CcSEcCtD
Quetiapine—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	2.9e-06	4.77e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RAF1—kidney cancer	2.9e-06	4.76e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.9e-06	4.76e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.9e-06	4.76e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—RELA—kidney cancer	2.9e-06	4.75e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RAF1—kidney cancer	2.89e-06	4.75e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—RELA—kidney cancer	2.89e-06	4.74e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MTOR—kidney cancer	2.89e-06	4.74e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RAF1—kidney cancer	2.88e-06	4.73e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MYC—kidney cancer	2.88e-06	4.73e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—RELA—kidney cancer	2.88e-06	4.73e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.88e-06	4.72e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	2.88e-06	4.72e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL2—kidney cancer	2.87e-06	4.72e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.87e-06	4.71e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—RELA—kidney cancer	2.87e-06	4.71e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.87e-06	4.71e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—KRAS—kidney cancer	2.86e-06	4.7e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	2.86e-06	4.7e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RAF1—kidney cancer	2.86e-06	4.69e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	2.85e-06	4.68e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.85e-06	4.67e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCND1—kidney cancer	2.85e-06	4.67e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—RELA—kidney cancer	2.84e-06	4.67e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—JUN—kidney cancer	2.84e-06	4.66e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.84e-06	4.66e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.84e-06	4.66e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.83e-06	4.65e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MTOR—kidney cancer	2.83e-06	4.65e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.83e-06	4.64e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	2.82e-06	4.64e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MTOR—kidney cancer	2.82e-06	4.64e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MAPK3—kidney cancer	2.82e-06	4.63e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	2.82e-06	4.63e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MAPK1—kidney cancer	2.82e-06	4.63e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2.82e-06	4.62e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—KRAS—kidney cancer	2.82e-06	4.62e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MTOR—kidney cancer	2.81e-06	4.62e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—kidney cancer	2.8e-06	4.61e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	2.8e-06	4.6e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—JUN—kidney cancer	2.8e-06	4.59e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MTOR—kidney cancer	2.79e-06	4.58e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MAPK3—kidney cancer	2.78e-06	4.57e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	2.78e-06	4.57e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	2.78e-06	4.56e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—KRAS—kidney cancer	2.78e-06	4.56e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	2.77e-06	4.56e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PTEN—kidney cancer	2.75e-06	4.51e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MYC—kidney cancer	2.74e-06	4.51e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—POMC—kidney cancer	2.72e-06	4.46e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MYC—kidney cancer	2.71e-06	4.45e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.71e-06	4.45e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MYC—kidney cancer	2.71e-06	4.45e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	2.71e-06	4.44e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	2.7e-06	4.44e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—PIK3CA—kidney cancer	2.7e-06	4.44e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	2.69e-06	4.41e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MAPK1—kidney cancer	2.68e-06	4.41e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTEN—kidney cancer	2.67e-06	4.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.67e-06	4.38e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.66e-06	4.37e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—KRAS—kidney cancer	2.66e-06	4.37e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.66e-06	4.36e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	2.66e-06	4.36e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—POMC—kidney cancer	2.65e-06	4.36e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	2.65e-06	4.35e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—kidney cancer	2.65e-06	4.35e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	2.65e-06	4.35e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MAPK1—kidney cancer	2.65e-06	4.35e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	2.65e-06	4.34e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	2.64e-06	4.34e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.63e-06	4.32e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	2.63e-06	4.32e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—kidney cancer	2.62e-06	4.3e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.62e-06	4.3e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.62e-06	4.3e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—kidney cancer	2.62e-06	4.29e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.61e-06	4.28e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—kidney cancer	2.61e-06	4.28e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—kidney cancer	2.6e-06	4.27e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—kidney cancer	2.6e-06	4.27e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—kidney cancer	2.59e-06	4.26e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—PIK3CA—kidney cancer	2.59e-06	4.25e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—kidney cancer	2.59e-06	4.24e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCND1—kidney cancer	2.58e-06	4.24e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.58e-06	4.24e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—JUN—kidney cancer	2.58e-06	4.23e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.57e-06	4.21e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—kidney cancer	2.56e-06	4.2e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.56e-06	4.2e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	2.55e-06	4.19e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.55e-06	4.19e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.55e-06	4.19e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—kidney cancer	2.54e-06	4.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.54e-06	4.17e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—JUN—kidney cancer	2.54e-06	4.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCND1—kidney cancer	2.54e-06	4.16e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—KRAS—kidney cancer	2.54e-06	4.16e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—JUN—kidney cancer	2.53e-06	4.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.53e-06	4.15e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—JUN—kidney cancer	2.52e-06	4.14e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.52e-06	4.14e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.52e-06	4.13e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.52e-06	4.13e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—JUN—kidney cancer	2.51e-06	4.13e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	2.51e-06	4.13e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.51e-06	4.12e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.5e-06	4.11e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—kidney cancer	2.5e-06	4.11e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—KRAS—kidney cancer	2.5e-06	4.11e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—KRAS—kidney cancer	2.5e-06	4.11e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—POMC—kidney cancer	2.5e-06	4.11e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.5e-06	4.1e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.5e-06	4.1e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PTEN—kidney cancer	2.49e-06	4.09e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—JUN—kidney cancer	2.49e-06	4.09e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.49e-06	4.09e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.48e-06	4.08e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	2.48e-06	4.07e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.47e-06	4.06e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—kidney cancer	2.47e-06	4.06e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.46e-06	4.05e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.45e-06	4.03e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PTEN—kidney cancer	2.45e-06	4.02e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTEN—kidney cancer	2.45e-06	4.02e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	2.44e-06	4.01e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MYC—kidney cancer	2.44e-06	4.01e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.44e-06	4.01e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PTEN—kidney cancer	2.44e-06	4.01e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.43e-06	3.99e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.43e-06	3.98e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.42e-06	3.98e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.41e-06	3.96e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.41e-06	3.95e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.4e-06	3.94e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	2.39e-06	3.93e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.39e-06	3.92e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.38e-06	3.91e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.37e-06	3.89e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—kidney cancer	2.37e-06	3.88e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MYC—kidney cancer	2.36e-06	3.87e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	2.35e-06	3.85e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MYC—kidney cancer	2.35e-06	3.85e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	2.33e-06	3.82e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PIK3CA—kidney cancer	2.32e-06	3.81e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.31e-06	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.31e-06	3.8e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.31e-06	3.79e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.31e-06	3.79e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.31e-06	3.79e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—PIK3CA—kidney cancer	2.3e-06	3.77e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	2.3e-06	3.77e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.3e-06	3.77e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.29e-06	3.76e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MYC—kidney cancer	2.28e-06	3.75e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—KRAS—kidney cancer	2.26e-06	3.71e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—kidney cancer	2.25e-06	3.7e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.25e-06	3.7e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.25e-06	3.69e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	2.23e-06	3.67e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.23e-06	3.66e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—kidney cancer	2.22e-06	3.65e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—kidney cancer	2.22e-06	3.65e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.22e-06	3.64e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.21e-06	3.63e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	2.2e-06	3.62e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.2e-06	3.61e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	2.2e-06	3.61e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.19e-06	3.6e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.18e-06	3.58e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2.18e-06	3.57e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	2.17e-06	3.56e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.17e-06	3.56e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—kidney cancer	2.17e-06	3.56e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.13e-06	3.5e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—kidney cancer	2.12e-06	3.47e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—KRAS—kidney cancer	2.11e-06	3.46e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	2.1e-06	3.44e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK3—kidney cancer	2.09e-06	3.43e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	2.09e-06	3.42e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	2.08e-06	3.41e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	2.08e-06	3.41e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	2.08e-06	3.41e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MYC—kidney cancer	2.07e-06	3.4e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	2.06e-06	3.38e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	2.05e-06	3.37e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PIK3CA—kidney cancer	2.05e-06	3.37e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MYC—kidney cancer	2.04e-06	3.35e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MYC—kidney cancer	2.03e-06	3.34e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MYC—kidney cancer	2.03e-06	3.33e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.03e-06	3.33e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MYC—kidney cancer	2.02e-06	3.32e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.02e-06	3.31e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.01e-06	3.3e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2e-06	3.29e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MYC—kidney cancer	2e-06	3.29e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MYC—kidney cancer	2e-06	3.28e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.99e-06	3.27e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.99e-06	3.27e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.99e-06	3.27e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.99e-06	3.27e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	1.98e-06	3.26e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	1.98e-06	3.25e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.96e-06	3.22e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.95e-06	3.21e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	1.94e-06	3.18e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—kidney cancer	1.94e-06	3.18e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—kidney cancer	1.93e-06	3.17e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—KRAS—kidney cancer	1.91e-06	3.14e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.91e-06	3.13e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.91e-06	3.13e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTEN—kidney cancer	1.89e-06	3.1e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.88e-06	3.09e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.88e-06	3.09e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—KRAS—kidney cancer	1.88e-06	3.09e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—kidney cancer	1.88e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—KRAS—kidney cancer	1.87e-06	3.08e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—KRAS—kidney cancer	1.87e-06	3.07e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.85e-06	3.05e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.85e-06	3.04e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTEN—kidney cancer	1.85e-06	3.03e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.85e-06	3.03e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.84e-06	3.03e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.81e-06	2.98e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.76e-06	2.89e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTEN—kidney cancer	1.74e-06	2.86e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.73e-06	2.84e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.73e-06	2.84e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.73e-06	2.83e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.72e-06	2.83e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.72e-06	2.82e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.71e-06	2.81e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—kidney cancer	1.7e-06	2.79e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.7e-06	2.79e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.69e-06	2.78e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—kidney cancer	1.67e-06	2.75e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—kidney cancer	1.67e-06	2.74e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—kidney cancer	1.67e-06	2.73e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—kidney cancer	1.66e-06	2.73e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—kidney cancer	1.64e-06	2.7e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.64e-06	2.69e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—POMC—kidney cancer	1.63e-06	2.68e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.57e-06	2.59e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.52e-06	2.5e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.33e-06	2.19e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.3e-06	2.14e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.3e-06	2.14e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.23e-06	2.01e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTEN—kidney cancer	1.14e-06	1.87e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.02e-07	1.32e-05	CbGpPWpGaD
